Testing services for Synovasure™ LDT, the company’s joint infection test, are provided through CD Diagnostics’ CLIA lab in Towson, Maryland. Results are turned around to physicians within 24hrs.
Richard Birkmeyer, CEO of CD Diagnostics stated, “We are very excited about our feature on Health Heroes. We believe that our breakthrough technology will have a tremendous impact on the orthopaedic community and are pleased to shed light on joint infection, a serious condition that negatively affects joint replacement patients worldwide.”
“When discussing technology, the true marvels today are happening behind closed doors,” said Michele Nehls, producer for the Health Heroes series. “I’m proud to be able to bring an inside perspective to the Health Heroes audience.”
About CD Diagnostics:
CD Diagnostics is a leader in joint fluid analysis focused on developing novel diagnostic tests for joint disease. The Company aims to improve patient outcomes through innovative technologies that provide more accurate and rapid diagnosis for joint pain and infection. As part of its commitment to joint fluid research, CD Diagnostics is creating a repository of joint fluid samples from a global network of physicians to facilitate biomarker screening services for synovial and spinal fluids. Combining biomarker identification with patented technology and expertise in immunoassay development and manufacturing, CD Diagnostics is developing a range of products that address challenging diagnostic determinations in joint health and therapeutic outcomes.
For more information, visit: http://www.cddiagnostics.com or call (484) 476-4800.
About Health He
Copyright©2012 Vocus, Inc.
All rights reserved